NCT00258310 2023-03-10
Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
Barbara Ann Karmanos Cancer Institute
University of Louisville